Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories™

Journal of Immunological Methods

Volumn 268, Issue 2, 2002, Pages 131-140

  Berger, Thomas G ^a   Feuerstein, Bernadette ^a   Strasser, Erwin ^a   Hirsch, Ute ^a   Schreiner, Doris ^a   Schuler, Gerold ^a   Schuler Thurner, Beatrice ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cell factories ; Closed system; Dendritic cells; Immunotherapy; Vaccination

Indexed keywords

CD83 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOTOXIN; PROSTAGLANDIN E2;

ADOPTIVE IMMUNOTHERAPY; APHERESIS; ARTICLE; BLOOD; CANCER IMMUNIZATION; CANCER REGRESSION; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; CULTURE VESSEL; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOLOGICAL TECHNIQUE; MELANOMA; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; REPRODUCIBILITY; STEM CELL;

BLOOD COMPONENT REMOVAL; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SURVIVAL; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; MONOCYTES; PHENOTYPE; T-LYMPHOCYTES;

EID: 0037107533     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00189-8     Document Type: Article

References (21)

1. Banchereau J., Palucka A.K., Dhodapkar M., Burkeholder S., Taquet N., Rolland A., Taquet S., Coquery S., Wittkowski K.M., Bhardwaj N., Pineiro L., Steinman R., Fay J. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res. 61:2001;6451.
2. Banchereau J., Schuler-Thurner B., Palucka A.K., Schuler G. Dendritic cells as vectors for therapy. Cell. 106(3):2001;271. Review.
3. Bender A., Sapp M., Schuler G., Steinman R.M., Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods. 196:1996;121.
4. Bernard J., Ittelet D., Christoph A., Potron G., Adjizian J.C., Kochman S., Lopez M. Adherent-free generation of functional dendritic cells from purified blood monocytes in view of potential clinical use. Hematol. Cell Ther. 40:1998;17.
5. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:2001;233.
6. Feuerstein B., Berger T.G., Maczek C., Roder C., Schreiner D., Hirsch U., Haendle I., Leisgang W., Glaser A., Kuss O., Diepgen T.L., Schuler G., Schuler-Thurner B. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J. Immunol. Methods. 245:2000;15.
7. Fong L., Hou Y., Rivas A., Benike C., Yuen A., Fisher G.A., Davis M.M., Engleman E.G. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. U. S. A. 98:2001;8809.
8. Glaser A., Schuler-Thurner B., Feuerstein B., Zingsem J., Zimmermann R., Weisbach V., Eckstein R. Collection of MNCs with two cell separators for adoptive immunotherapy in patients with stage IV melanoma. Transfusion. 41:2001;117.
9. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., Engleman E.G., Levy R. Vaccination of patients with B cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:1996;52.
10. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., Enk A.H. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27:1997;3135.
11. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213.
12. Jonuleit H., Giesecke-Tuettenberg A., Tuting T., Thurner-Schuler B., Stuge T.B., Paragnik L., Kandemir A., Lee P.P., Schuler G., Knop J., Enk A.H. A comparison of two types of dendritic cells as adjuvants for the induction of melanoma-specific T cell responses in humans following intranodal injection. Int. J. Cancer. 93:2001;243.
13. Miltenyi S., Muller W., Weichel W., Radbruch A. High gradient magnetic cell separation with MACS. Cytometry. 11:1990;231.
14. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:1998;328.
15. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods. 196:1996;137.
16. Schuler-Thurner B., Dieckmann D., Keikavoussi P., Bender A., Maczek C., Jonuleit H., Roder C., Haendle I., Leisgang W., Dunbar R., Cerundolo V., von den Driesch P., Knop J., Brocker E.B., Enk A., Kampgen E., Schuler G. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J. Immunol. 165:2000;3492.
17. Schuler-Thurner B., Schultz E., Berger T.G., Weinlich G., Ebner S., Woerl P., Bender A., Feuerstein B., Fritsch P.O., Romani N., Schuler G. Rapid induction of type one helper T cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med. 195:2002;1279.
18. Steinman R.M., Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer. 94:2001;459. Review.
19. Suen Y., Lee S.M., Aono F., Hou S., Loudovaris M., Ofstein G., Bender J.G. Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC. Cytotherapy. 3:2001;365.
20. Thurner B., Haendle I., Roder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., von Den Driesch P., Broecker E.B., Steinman R.M., Enk A., Kampgen E., Schuler G. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190:1999;1669.
21. Thurner B., Roder C., Dieckmann D., Heuer M., Kruse M., Glaser A., Keikavoussi P., Kampgen E., Bender A., Schuler G. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J. Immunol. Methods. 223:1999;1.